Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
-
69073
- 01
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
MEDA Pharmaceuticals Switzerland GmbH - Enrylaze 10 mg/vial, Injektionslösung
Swissmedic Registration
69073
Sequence
01
Product name
Enrylaze 10 mg/vial
Description
Injektionslösung
ATC-Classification
L01XX02
ATC-Description
Asparaginase
Introduction of Sequence
18.04.2024
Composition
crisantaspasum 10 mg, trehalosum dihydricum, natrii chloridum, dinatrii phosphas, natrii dihydrogenophosphas monohydricus, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp. natrium ca. 1 mg.
Packungsbestandteile
Galenic Form
Injection solution
Excipiens
Active Agent
Dose
Crisantaspasum
10mg / 0.5ml
Inactive agents
Disodium Phosphate
Sodium Chloride
Sodium Dihydrogenophosphate Monohydrate
Sodium Hydroxide
Polysorbatum 80
Trehalosum Dihydricum
Package number
Package Size
EFP
CP
Category
SL
Out of trade (MedRef)
001
3
PR
PR
A
No
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
